140 related articles for article (PubMed ID: 18045183)
1. Cyclooxygenase-2 (COX-2)--a therapeutic target in liver cancer?
Breinig M; Schirmacher P; Kern MA
Curr Pharm Des; 2007; 13(32):3305-15. PubMed ID: 18045183
[TBL] [Abstract][Full Text] [Related]
2. [Significance of cyclooxygenase-2 as a chemotherapeutic target in hepatocellular carcinoma].
Kern MA; Schirmacher P; Breinig M
Verh Dtsch Ges Pathol; 2007; 91():257-68. PubMed ID: 18314623
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenases in hepatocellular carcinoma.
Cervello M; Montalto G
World J Gastroenterol; 2006 Aug; 12(32):5113-21. PubMed ID: 16937518
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
Kern MA; Haugg AM; Koch AF; Schilling T; Breuhahn K; Walczak H; Fleischer B; Trautwein C; Michalski C; Schulze-Bergkamen H; Friess H; Stremmel W; Krammer PH; Schirmacher P; Müller M
Cancer Res; 2006 Jul; 66(14):7059-66. PubMed ID: 16849551
[TBL] [Abstract][Full Text] [Related]
5. COX-2 - a target for preventing hepatic carcinoma?
Rahman MA; Kohno H; Nagasue N
Expert Opin Ther Targets; 2002 Aug; 6(4):483-90. PubMed ID: 12223062
[TBL] [Abstract][Full Text] [Related]
6. The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma.
Chi-Man Tang T; Tung-Ping Poon R; Fan ST
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S311-6. PubMed ID: 16507400
[TBL] [Abstract][Full Text] [Related]
7. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
8. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 in hepatocellular carcinoma.
Wu T
Cancer Treat Rev; 2006 Feb; 32(1):28-44. PubMed ID: 16337744
[TBL] [Abstract][Full Text] [Related]
10. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
[TBL] [Abstract][Full Text] [Related]
11. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
Zhao QT; Yue SQ; Cui Z; Wang Q; Cui X; Zhai HH; Zhang LH; Dou KF
Life Sci; 2007 Jan; 80(5):484-92. PubMed ID: 17097688
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
[TBL] [Abstract][Full Text] [Related]
13. Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells.
Pan YY; Xu SP; Jia XY; Xu HQ; Zhang Y; Rui LX; Wei W
Exp Oncol; 2007 Mar; 29(1):23-9. PubMed ID: 17431384
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
[TBL] [Abstract][Full Text] [Related]
15. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
Nagahara T; Okano J; Murawaki Y
Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
[TBL] [Abstract][Full Text] [Related]
19. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.
Xu Y; Zhao W; Xu J; Li J; Hong Z; Yin Z; Wang X
Oncotarget; 2016 Feb; 7(8):8866-78. PubMed ID: 26758420
[TBL] [Abstract][Full Text] [Related]
20. Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest.
Baek JY; Hur W; Wang JS; Bae SH; Yoon SK
World J Gastroenterol; 2007 Feb; 13(8):1175-81. PubMed ID: 17451196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]